This Article Full Text Full Text (PDF) All Versions of this Article: 110/14/2003    most recent 01.CIR.0000143630.14515.7Cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bourraindeloup, M. Articles by Pecker, F. Search for Related Content PubMed PubMed Citation Articles by Bourraindeloup, M. Articles by Pecker, F. Related Collections Remodeling Cardiovascular Pharmacology Myocardial cardiomyopathy disease Chronic ischemic heart disease

(Circulation. 2004;110:2003-2009.)
© 2004 American Heart Association, Inc.

Hypertension

N-Acetylcysteine Treatment Normalizes Serum Tumor Necrosis Factor- Level and Hinders the Progression of Cardiac Injury in Hypertensive Rats

Marie Bourraindeloup, MD; Christophe Adamy, PhD; Gabriele Candiani, MSci; Michel Cailleret, MSci; Marie-Claude Bourin, PhD; Thierry Badoual, MD; Jin Bo Su, PhD; Sylviane Adubeiro; Françoise Roudot-Thoraval, MD; Jean-Luc Dubois-Rande, MD, PhD; Luc Hittinger, MD, PhD; Françoise Pecker, PhD

From the Fédération de Cardiologie, Hôpital Henri Mondor (M.B., J.-L.D.-R., L.H.); INSERM Unité 581, Hôpital Henri Mondor (C.A., G.C., M.C., M.-C.B., S.A., F.P.); INSERM Unité 400, Faculté de Médecine (T.B., J.B.S., J.-L.D.-R., L.H.); and Service de Santé Publique, Hôpital Henri Mondor (F.R.-T.), Créteil, France.

Correspondence to Françoise Pecker, INSERM Unité 581, Hôpital Henri Mondor, 94010 Créteil, France. E-mail francoise.pecker{at}im3.inserm.fr

Received May 10, 2004; revision received July 13, 2004; accepted July 15, 2004.

Background— Studies in isolated cardiomyocytes showed that replenishment in cellular glutathione, achieved with the glutathione precursor N-acetylcysteine (NAC), abrogated deleterious effects of tumor necrosis factor- (TNF-).

Methods and Results— We examined the ability of NAC to limit the progression of cardiac injury in the rat model of hypertension, induced by the nitric oxide synthase inhibitor N^G-nitro-L-arginine methyl ester (L-NAME) (50 mg/kg per day SC) and high-salt diet (HS) (8% NaCl). Four-week HS/L-NAME administration induced hypertension (193±8 versus 122±4 mm Hg for low-salt diet [LS] group) and left ventricular (LV) dysfunction, revealed by echocardiography and characterized by decreased LV shortening fraction (38±2% versus 49±4% for LS group; P<0.05) and decreased LV posterior wall thickening (49±3% versus 70±4% for LS group; P<0.05). LV dysfunction worsened further after 6-week HS/LNAME administration. Importantly, increase in serum TNF- level was strongly correlated with shortening fraction decrease and cardiac glutathione depletion. NAC (75 mg/d) was given as a therapeutic treatment in a subgroup of HS/L-NAME animals during weeks 5 and 6 of HS/L-NAME administration. NAC treatment, which replenished cardiac glutathione, had no effect on hypertension but reduced LV remodeling and dysfunction, normalized serum TNF- level, and limited activation of matrix metalloproteinases -2 and -9 and collagen deposition in LV tissues.

Conclusions— These findings suggest that glutathione status determines the adverse effects of TNF- in cardiac failure and that TNF- antagonism may be achieved by glutathione supplementation.

Key Words: tumor necrosis factor • acetylcysteine • glutathione • heart failure • N^G-nitroarginine methyl ester

This article has been cited by other articles:

				T.-M. Lee, P.-Y. Lai, and N.-C. Chang Effect of N-acetylcysteine on sympathetic hyperinnervation in post-infarcted rat hearts Cardiovasc Res, September 16, 2009; (2009) cvp286v2. [Abstract] [Full Text] [PDF]

				N. Defer, J. Wan, R. Souktani, B. Escoubet, M. Perier, P. Caramelle, S. Manin, V. Deveaux, M.-C. Bourin, A. Zimmer, et al. The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy FASEB J, July 1, 2009; 23(7): 2120 - 2130. [Abstract] [Full Text] [PDF]

				C. Pavoine and F. Pecker Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology Cardiovasc Res, May 1, 2009; 82(2): 175 - 183. [Abstract] [Full Text] [PDF]

				M. Shahid, J. Francis, and D. S. A. Majid Tumor necrosis factor-{alpha} induces renal vasoconstriction as well as natriuresis in mice Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1836 - F1844. [Abstract] [Full Text] [PDF]

				N. Defer, A. Azroyan, F. Pecker, and C. Pavoine TNFR1 and TNFR2 Signaling Interplay in Cardiac Myocytes J. Biol. Chem., December 7, 2007; 282(49): 35564 - 35573. [Abstract] [Full Text] [PDF]

				M. Canton, A. Skyschally, R. Menabo, K. Boengler, P. Gres, R. Schulz, M. Haude, R. Erbel, F. Di Lisa, and G. Heusch Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization Eur. Heart J., April 1, 2006; 27(7): 875 - 881. [Abstract] [Full Text] [PDF]